CLINICAL_TRIALS
trial_result
· 2016-01-20
Clinical Trial Update: Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) [Phase 2]
Summary
Phase 2 trial investigating treatment of sarcopenia in post-hip fracture patients was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hip Fracture | Phase 2 | Status: TERMINATED